Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.28 USD | +3.44% | -4.17% | +180.01% |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
May. 09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VERA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +4.38% | -4.17% | +180.01% | +440.34% | - | 2.24B |
- Stock Market
- Equities
- VERA Stock
- Charts Vera Therapeutics, Inc.
- Relative Strength Chart